NCT06851598View on ClinicalTrials.gov

Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

March 1, 2025

Conditions
Premature Ejaculation
Interventions
DRUG

25 units botox

25 units of botox injection into ischiocavernosus muscle

DRUG

50 units Botox

50 Units botox injection into ischiocavernosus muscle

DRUG

75 units Botox

75 units botox injection into ischiocavernosus muscle

Trial Locations (1)

Unknown

Faculty of Medicine, Al-Azhar University, Cairo

All Listed Sponsors
lead

Abdallah Mohamed Abdallah Mohamed Elgendy

OTHER

NCT06851598 - Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation | Biotech Hunter | Biotech Hunter